Skip to main content
. 2023 Aug 28;8(11):2482–2485. doi: 10.1016/j.ekir.2023.08.032

Figure 1.

Figure 1

Cumulative incidence plot of time from capmatinib administration to AKI, with death as a competing risk. On the y-axis is the probability of the 2 competing events: AKI or death. The x-axis represents time in months. N represents the number of patients each time. AKI, acute kidney injury.